New York State Common Retirement Fund
MNPR icon

New York State Common Retirement Fund’s Monopar Therapeutics MNPR Stock Holding History

New York State Common Retirement Fund’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
2,400
+1,200
+100% +$74.3K ﹤0.01% 2324
2026
Q1 		$65.7K Hold
1,200
– – ﹤0.01% 2720
2025
Q4 		$78.4K Hold
1,200
– – ﹤0.01% 2727
2025
Q3 		$98K Sell
1,200
-1,700
-59% -$76K ﹤0.01% 2629
2025
Q2 		$104K Buy
+2,900
New +$105K ﹤0.01% 2590

Other funds holding MNPR

GL
Gerber LLC Columbus, Ohio $213M AUM 25.63% 1-Year Est. Return
MIM
Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

New York State Common Retirement Fund's MNPR Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Monopar Therapeutics (MNPR) stake by 100% in Q2 2026, buying an estimated $74.3K and bringing the position to 2,400 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #2324.

New York State Common Retirement Fund first reported a position in MNPR in Q2 2025 and has held it in 5 quarters since. 8 funds tracked by Wall St. Rank hold MNPR as of Q2 2026.

  • New York State Common Retirement Fund held 2,400 shares of Monopar Therapeutics worth $222K as of Q2 2026.
  • New York State Common Retirement Fund bought 1,200 Monopar Therapeutics shares in Q2 2026, an estimated $74.3K.
  • Monopar Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2324 holding.
  • New York State Common Retirement Fund first reported a position in Monopar Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 8 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.